1.
Santini D, Vincenzi B, Rosolowski M, Altucci L, Campioni M, Loeffler M, Baldi A, Tonini G. Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3). Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2024 Nov. 23];2(3). Available from: https://www.pagepress.org/journals/hmr/article/view/365